Fig. 4

Outcome of PDAC patient in homologous recombination (HR) gene mutations status. A Median overall survival of 527 PDAC patients with germline HR gene mutations, other gene mutations or no mutation. B Median overall survival of 320 stage III/IV PDAC patients with or without HR gene mutations treated with 1L platinum-based or platinum-free chemotherapy